跳至主要内容
临床试验/NCT04880603
NCT04880603终止2 期

Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site

Nebraska Methodist Health System2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2021年4月5日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
5
试验地点
2
主要终点
Tendon exposure

研究概览

简要总结

Adult patients undergoing a radial forearm free flap or ulnar forearm free flap will be randomized to the use of the Restrata graft in combination with split-thickness skin graft for reconstruction. Photos will document whether the Restata graft aids in the healing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients age 19 or greater that will undergo radial forearm free flap or ulnar free flap.
  • Photo documentation of wound bed at two weeks and four weeks must be obtainable either by physician or patient.

排除标准

  • Active systemic immunosuppression (active use of high-dose steroids (≥40mg prednisone daily or equivalent) or other immunosuppressive medications OR medical conditions causing immunosuppression, i.e. human immunodeficiency virus etc).
  • Diabetes mellitus with most recent Hemoglobin A1c ≥10.0 within 30 days prior to surgery.
  • Morbid obesity (BMI >40).
  • Inability to maintain wrist immobilization for full planned period.
  • Severe malnutrition (prealbumin levels <10 mg per dL within 30 days prior to surgery OR BMI <15 (very severely underweight).
  • Other conditions felt to significantly impair wound healing per surgeon discretion

结局指标

主要结局

Tendon exposure

时间窗: 4 weeks post-operation

Tendon exposure at four weeks post-operatively (Yes/No).

Percentage of surface area

时间窗: 4 weeks post operation

Percentage of surface area of split-thickness skin graft incorporation at four weeks postoperatively.

次要结局

未报告次要终点

研究者

发起方
Nebraska Methodist Health System
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Utility of Restrata With Split-thickness Skin Graft... | 临床试验